Page 221 - IJB-10-5

International Journal of Bioprinting Biomimetic osteochondral scaffold

an innovative strategy for constructing 3D biomimetic- experimental models. Biology. 2020;9(8):194.
engineered osteochondral tissue with great potential for doi: 10.3390/biology9080194
osteochondral regeneration. 3. Abramoff B, Caldera FE. Osteoarthritis pathology,
diagnosis, and treatment options. Méd Clin North Am.
Acknowledgments 2020;104(2):293-311.
doi: 10.1016/j.mcna.2019.10.007
None.
4. Hermann W, Lambova S, Muller-Ladner U. Current
Funding treatment options for osteoarthritis. Curr Rheumatol Rev.
2017;14(2):108-116.
This work was supported by the National Key R&D Program doi: 10.2174/1573397113666170829155149
of China (2022YFB4600600), the National Natural Science 5. Madry H. Surgical therapy in osteoarthritis. Osteoarthr
Foundation of China (32271181 and 82300018), the Cartil. 2022;30(8):1019-1034.
Guangdong Basic and Applied Basic Research Foundation doi: 10.1016/j.joca.2022.01.012
(2021A1515111074), the Department of Education of 6. Wei W, Dai H. Articular cartilage and osteochondral tissue
Guangdong Province, China (2021ZDZX2014), the engineering techniques: recent advances and challenges.
Dongguan Science and Technology of Social Development Bioact Mater. 2021;6(12):4830-4855.
Program, Guangdong, China (20211800904542). doi: 10.1016/j.bioactmat.2021.05.011
Conflict of interest 7. Zhou L, Gjvm VO, Malda J, et al. Innovative tissue‐
engineered strategies for osteochondral defect repair and
The authors declare no conflicts of interest. regeneration: current progress and challenges. Adv Healthc
Mater. 2020;9(23):e2001008.
Author contributions doi: 10.1002/adhm.202001008
Conceptualization: Yaobin Wu, Chong Wang, 8. Colella F, Garcia JP, Sorbona M, et al. Drug delivery in
Wenhua Huang, intervertebral disc degeneration and osteoarthritis: selecting
the optimal platform for the delivery of disease-modifying
Formal analysis: Zhuosheng Lin, Ziyue Li, Zi Yan agents. J Control Release. 2020;328:985-999.
Investigation: Weiwei Su, Shiyu Li, Panjing Yin doi: 10.1016/j.jconrel.2020.08.041
Methodology: Weihan Zheng, Ling Wang
Writing – original draft: Weiwei Su 9. Rahimi M, Charmi G, Matyjaszewski K, Banquy X,
Pietrasik J. Recent developments in natural and synthetic
Writing – review & editing: Shiyu Li, Chong Wang, polymeric drug delivery systems used for the treatment of
Wenhua Huang osteoarthritis. Acta Biomater. 2021;123:31-50.
doi: 10.1016/j.actbio.2021.01.003
Ethics approval and consent to participate
10. Zhan A, Chen L, Sun W, et al. Enhancement of diabetic
Not applicable. wound healing using a core-shell nanofiber platform with
sequential antibacterial, angiogenic, and collagen deposition
Consent for publication activities. Mater Des. 2022;218:110660.
doi: 10.1016/j.matdes.2022.110660
Not applicable.
11. He W, Li C, Zhao S, et al. Integrating coaxial electrospinning
Availability of data and 3D printing technologies for the development of
biphasic porous scaffolds enabling spatiotemporal control
Data is available from the corresponding author upon in tumor ablation and osteochondral regeneration. Bioact
reasonable request. Mater. 2024;34:338-353.
doi: 10.1016/j.bioactmat.2023.12.020
References 12. Li S, Zheng W, Deng W, et al. Logic‐based strategy for
spatiotemporal release of dual extracellular vesicles in
1. Olstad K, Ekman S, Carlson CS. An update on the osteoarthritis treatment. Adv Sci. (Weinh). 2024:e2403227.
pathogenesis of osteochondrosis. Vet Pathol. 2015;52(5):7 doi: 10.1002/advs.202403227
85-802. 13. Bhat BB, Mehta CH, Suresh A, Velagacherla V, Nayak
doi: 10.1177/0300985815588778
UY. Controlled release technologies for chronotherapy:
2. He Y, Li Z, Alexander PG, et al. Pathogenesis of osteoarthritis: current status and future perspectives. Curr Pharm Des.
risk factors, regulatory pathways in chondrocytes, and 2023;29(14):1069-1091.

Volume 10 Issue 5 (2024) 213 doi: 10.36922/ijb.3229